"We plan to introduce 25 new therapies by 2025 globally, with focus on oncology & hospital products"
In a significant move to bring critical research and development (R&D) capabilities under one roof, American firm Pfizer has set up a global drug development centre at the Indian Institute of Technology (IIT) Madras Research Park in Chennai. With an investment of more than Rs 150 crore, this 61,000 sq ft research and technology centre will be a part of a network of 12 global centers set up worldwide, and it is the first and only one at present being set up by Pfizer in Asia. To find out more...
United States Tamil Nadu Foundation For Innovation Technology Transfer Madras Research Park Sip Programme
Source: biospectrumindia.com